Lee Andrew W, Truong Tuan, Bickham Kara, Fonteneau Jean-Francois, Larsson Marie, Da Silva Ida, Somersan Selin, Thomas Elaine K, Bhardwaj Nina
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, NY 10021, USA.
Vaccine. 2002 Dec 19;20 Suppl 4:A8-A22. doi: 10.1016/s0264-410x(02)00382-1.
Dendritic cells (DCs) can induce tumor- or pathogen-specific T cell responses in humans. We comprehensively compared the clinically available DC maturation stimuli for their ability to promote uniformly mature DCs that elicit higher levels of T cell responses. We compared the standard maturation stimulus, autologous monocyte-conditioned medium (MCM), with a synthetic double stranded RNA (poly I:C), soluble CD40 ligand trimer, and a defined cocktail of cytokines (TNF-alpha, IL-1 beta, IL-6) and PGE(2) to promote mature phenotype and function in human monocyte-derived DCs. The cocktail was the most efficient despite the lack of induction of IL-12p70. While these results support the use of the MCM-mimic cocktail in clinical DC immunotherapy trials, the roles of it's individual constituents remain to be completely defined.
树突状细胞(DCs)可在人类中诱导肿瘤或病原体特异性T细胞反应。我们全面比较了临床上可用的DC成熟刺激剂促进均匀成熟DCs的能力,这些成熟DCs能引发更高水平的T细胞反应。我们将标准成熟刺激剂自体单核细胞条件培养基(MCM)与合成双链RNA(聚肌胞苷酸)、可溶性CD40配体三聚体以及细胞因子(肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6)和前列腺素E2的特定混合物进行比较,以促进人单核细胞衍生DCs的成熟表型和功能。尽管未诱导出白细胞介素-12p70,但该混合物是最有效的。虽然这些结果支持在临床DC免疫治疗试验中使用模拟MCM的混合物,但其各个成分的作用仍有待完全明确。